The growth of the Marine Derived Pharmaceuticals Market is fueled by heightened investments in marine biotechnologies and the growing need for innovative natural medicines sourced from marine life, including sponges, corals, and deep-sea bacteria...
The domestically created E-beam technology can enable India to become a worldwide leader in the sterilization of medical devices and various radiation-related applications. India reached a significant milestone when the electron beam (E-beam)...
Biocon Biologics, a branch of Biocon, has gained access to the market for the biosimilar Ustekinumab in Europe, the United Kingdom (UK), Canada, and Japan. Ustekinumab is a human monoclonal antibody that inhibits the irregular regulation of...
In the first half of the current fiscal year, imports of surgical products and equipment reached $621.59 million, an increase from the $557.68 million recorded in the same period last fiscal year. Imports increased by 13.03 percent in terms of...
The increase in chronic illnesses is anticipated to drive the need for specialty generic products. There is expected to be a significant increase in the size of the specialty generics market in the coming years. The amount is projected to reach...
India's medical technology sector is projected to reach exports worth USD 20 billion by 2030. The industry body CII mentioned that in order to boost international shipments, the sector requires more government incentives and improved ease of doing...
The pharmaceutical sector is projected to reach $70.3 billion, with a 9 percent growth expected from FY25 to FY27, fueled by rising exports to nations such as the US, as well as by new products introduced by Indian pharmaceutical firms. It is...
In the upcoming five years, almost 70 percent of international pharmaceutical companies are predicted to experience yearly growth of over 10 percent in India. International pharmaceutical corporations have been essential in the change by bringing...
India's pharmaceutical industry, known for being a major player in global healthcare, is projected to reach an impressive value of USD 450 billion by 2047. India continues to be a major player in the international pharmaceutical market, with...
Many pharmaceutical companies prioritize digital transformation to enhance their ability to collect, analyze, and store data for future use, driving the increasing demand for the pharma 4.0 market. Utilizing industry 4.0 technology in the...